P innovation’s new, generic next-generation dry powder inhaler (DPI) filling technology has become available on the market.

L7 Informatics’ Marcia Blackmoore on how structured data, digital workflows, and real-time orchestration are helping CDMOs deliver at scale without compromising quality.

The U.S. Food and Drug Administration (FDA) has approved Abeona Therapeutics Inc.’s ZEVASKYN gene-modified cellular sheets.

New solutions support high-precision analytics for process development, batch release, and regulatory compliance.

Identiv has entered a strategic business development and marketing partnership with Tag-N-Trac to develop & commercialize ...

RoosterBio Inc. has partnered with Thermo Fisher Scientific to accelerate the availability of new, potentially life-saving ...

Lutris Pharma, a clinical-stage biopharmaceutical company, has appointed Sumant Ramachandra as CEO and a member of its Board ...

Veeva Systems has announced Veeva AI, a new initiative that adds artificial intelligence to the Veeva Vault Platform and ...

Olon Group, a global pharmaceutical CDMO, appointed Jérôme Bédier as CEO of its French entities and Andrea Conforto as M&S VP ...

Granata Bio has acquired Oviva Therapeutics, a women's health biotech company focused on advancing treatments that address ...

Cell and gene therapy manufacturing isn’t just complex—it’s interconnected, dynamic, and constantly evolving. Yet the systems ...

Merck KGaA, Darmstadt, Germany, a science and technology company, has entered into a definitive agreement to acquire ...